Can Inflammatory Indices Predict Sentinel Lymph Node Status in Patients with Early-stage Breast Cancer?

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2023 Aug 21

PMID 37603529

Authors

Hakan Balbaloglu

Ilhan Tasdoven

Guldeniz Karadeniz Cakmak

Affiliations

Soon will be listed here.

Abstract

Breast cancer research has focused on the early detection and treatment of breast cancer. Axillary lymph node status is essential for primary breast cancer staging, recurrence, and survival. The current quest for precision medicine is to identify predictive markers that offer the advantage of individualized treatment options. This study aimed to investigate the value of inflammatory indices in predicting positive sentinel nodes in breast cancer. We studied 602 patients with early-stage breast cancer who underwent sentinel lymph node biopsies (SLNB) at the Bülent Ecevit University General Surgery Clinic. We obtained data, including the clinical and demographic characteristics of the patients, such as age, histological type, and sentinel lymph nodes. Neutrophil, lymphocyte, platelet, and monocyte counts were obtained from preoperative complete blood count test data from the patient registry. The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic inflammatory index (SII), and sentinel lymph node biopsy were analyzed. Sentinel LAP was negative in 391 (65%) patients and positive in 211 (35%). In the receiver operating characteristic curve analysis, no significant difference was found between SLNB positivity and negativity in terms of NLR, PLR, LMR, or SII. In contrast to previous research, NLR, PLR, LMR, or SII did not affect SLNB positivity prediction in our study.

References

Giuliano A, Ballman K, McCall L, Beitsch P, Brennan M, Kelemen P . Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017; 318(10):918-926. PMC: 5672806. DOI: 10.1001/jama.2017.11470. View

Ahmed M, Purushotham A, Douek M . Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014; 15(8):e351-62. DOI: 10.1016/S1470-2045(13)70590-4. View

Tuomisto A, Makinen M, Vayrynen J . Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019; 25(31):4383-4404. PMC: 6710177. DOI: 10.3748/wjg.v25.i31.4383. View

Ibrahim A, Serkan Y, Tuba A, Erol B, Lutfi P . Can Neutrophil to Lymphocyte Ratio Be a Predictor Tool for The Non-Sentinel Lymph Node Metastasis in Breast Cancer?. Chirurgia (Bucur). 2019; 114(1):83-88. DOI: 10.21614/chirurgia.114.1.83. View

Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A . The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. J Surg Oncol. 2013; 108(7):481-5. DOI: 10.1002/jso.23424. View

Follacchio G, Monteleone F, Anibaldi P, De Vincentis G, Iacobelli S, Merola R . A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study. J Exp Clin Cancer Res. 2015; 34:113. PMC: 4596463. DOI: 10.1186/s13046-015-0230-x. View

Feng J, Chen S, Yang X . Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore). 2017; 96(4):e5886. PMC: 5287956. DOI: 10.1097/MD.0000000000005886. View

Tardioli S, Ballesio L, Gigli S, Di Pastena F, DOrazi V, Giraldi G . Wire-guided Localization in Non-palpable Breast Cancer: Results from Monocentric Experience. Anticancer Res. 2016; 36(5):2423-7. View

Mamounas E, Kuehn T, Rutgers E, von Minckwitz G . Current approach of the axilla in patients with early-stage breast cancer. Lancet. 2017; . DOI: 10.1016/S0140-6736(17)31451-4. View

10.

Yang L, Wang H, Ma J, Hao J, Zhang C, Ma Q . Association between the platelet to lymphocyte ratio, neutrophil to lymphocyte ratio and axillary lymph node metastasis in cT1N0 breast cancer patients. Am J Transl Res. 2021; 13(3):1854-1861. PMC: 8014375. View

11.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

12.

Smittenaar C, Petersen K, Stewart K, Moitt N . Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016; 115(9):1147-1155. PMC: 5117795. DOI: 10.1038/bjc.2016.304. View

13.

Peng H, Yang L, He B, Pan Y, Ying H, Sun H . Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC. J Clin Lab Anal. 2016; 31(5). PMC: 6816914. DOI: 10.1002/jcla.22075. View

14.

Liu D, Heij L, Czigany Z, Dahl E, Lang S, Ulmer T . The role of tumor-infiltrating lymphocytes in cholangiocarcinoma. J Exp Clin Cancer Res. 2022; 41(1):127. PMC: 8988317. DOI: 10.1186/s13046-022-02340-2. View

15.

Kootstra J, Hoekstra-Weebers J, Rietman J, De Vries J, Baas P, Geertzen J . A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Ann Surg Oncol. 2010; 17(9):2384-94. PMC: 2924495. DOI: 10.1245/s10434-010-0981-8. View

16.

Tonellotto F, Bergmann A, Abrahao K, de Aguiar S, Bello M, Thuler L . Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer. Eur J Breast Health. 2019; 15(2):76-84. PMC: 6456272. DOI: 10.5152/ejbh.2019.4414. View

17.

Manca G, Rubello D, Tardelli E, Giammarile F, Mazzarri S, Boni G . Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and Controversies. Clin Nucl Med. 2015; 41(2):126-33. DOI: 10.1097/RLU.0000000000000985. View

18.

Jiang N, Deng J, Liu Y, Ke B, Liu H, Liang H . The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers. 2014; 19(6):444-51. DOI: 10.3109/1354750X.2014.926567. View

19.

Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W . Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017; 111:176-181. DOI: 10.1016/j.lungcan.2017.07.024. View

20.

Arneth B . Tumor Microenvironment. Medicina (Kaunas). 2020; 56(1). PMC: 7023392. DOI: 10.3390/medicina56010015. View